Series date: 
01/01/2023 - 6:00am CST to 12/31/2023 - 11:59pm CST

OBJECTIVES: Upon completion of this activity, the participant should be able to:   (1) Identify the appropriate NCCN and ASH guidelines, (2) Recognize common presenting symptoms and understand treatment modalities for patients with leukemia.  (3) Analyze clinical trials available for leukemic patients through the Baylor Research Institute.

PLANNER/MODERATOR DISCLOSURE:  Charles Buess, MD, has no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Taylor Martinez at [email protected]

 

 

Series location: 
Baylor Charles A. Sammons Cancer Center - Dallas Campus
3410 Worth Street Ste 580
Dallas, TX 75246
United States

Sessions

Session Date
YYYYMMDD Dallas Hematology/Oncology Disease TB TEMPLATE 01/04/2023 - 12:30pm to 1:30pm CST
20230111 Dallas Hematology/Oncology Disease TB 01/11/2023 - 12:30pm to 1:30pm CST
20230118 Dallas Hematology/Oncology Disease TB 01/18/2023 - 12:30pm to 1:30pm CST
20230125 Dallas Hematology/Oncology Disease TB 01/25/2023 - 12:30pm to 1:30pm CST
CANCELLED - 20230201 Dallas Hematology/Oncology Disease TB 02/01/2023 - 12:30pm to 1:30pm CST
20230208 Dallas Hematology/Oncology Disease TB 02/08/2023 - 12:30pm to 1:30pm CST
20230215 Dallas Hematology/Oncology Disease TB 02/15/2023 - 12:30pm to 1:30pm CST
20230222 Dallas Hematology/Oncology Disease TB 02/22/2023 - 12:30pm to 1:30pm CST
20230301 Dallas Hematology/Oncology Disease TB 03/01/2023 - 12:30pm to 1:30pm CST
20230308 Dallas Hematology/Oncology Disease TB 03/08/2023 - 12:30pm to 1:30pm CST

Pages